Piotr Januszyk
Krakow, MA, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
The Influence of Salinomycin on the Expression Profile of mRNAs Encoding Selected Caspases and MiRNAs Regulating their Expression in Endometrial Cancer Cell Line.
Journal: Current pharmaceutical biotechnology
Published: February 09, 2020
Analysis of the Differences in the Expression of mRNAs and miRNAs Associated with Drug Resistance in Endometrial Cancer Cells Treated with Salinomycin.
Journal: Current pharmaceutical biotechnology
Published: February 04, 2020
Expression of Semaphorin 3B (SEMA3B) in Various Grades of Endometrial Cancer.
Journal: Medical science monitor : international medical journal of experimental and clinical research
Published: June 21, 2019
Variances in the Level of COX-2 and iNOS in Different Grades of Endometrial Cancer.
Journal: Current pharmaceutical biotechnology
Published: June 12, 2019
Expression Profile of VEGF-C, VEGF-D, and VEGFR-3 in Different Grades of Endometrial Cancer.
Journal: Current pharmaceutical biotechnology
Published: January 08, 2019
Evaluation of Changes in the Expression Pattern of EDIL3 in Different Grades of Endometrial Cancer.
Journal: Current pharmaceutical biotechnology
Published: January 04, 2019
Changes in Expression Pattern of SEMA3F Depending on Endometrial Cancer Grade - Pilot Study.
Journal: Current pharmaceutical biotechnology
Published: January 04, 2019
Assessment of the Usefulness of the SEMA5A Concentration Profile Changes as a Molecular Marker in Endometrial Cancer.
Journal: Current pharmaceutical biotechnology
Published: November 19, 2018
Expression of NRP-1 and NRP-2 in Endometrial Cancer.
Journal: Current pharmaceutical biotechnology
Published: September 11, 2018
Showing 1-10 of 10
Last Updated: 09/26/2026